Tetra Bio-Pharma Inc. Virtually Opens The Market
TORONTO, Aug. 7, 2020 /CNW/ - Dr. Guy Chamberland, CEO and Chief Regulatory Officer, Tetra Bio-Pharma Inc. (TSX: TBP), joined his team and Sophie Van Houtte, Head of Company Services, TMX Group, to celebrate the company's graduation from TSX Venture Exchange to Toronto Stock Exchange and open the market.
Tetra Bio-Pharma is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved and FDA reviewed and cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. With patients at the core of what they do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies. For more information, please visit www.tetrabiopharma.com.
For Market Openings: Media may pick up a feed from the TOC (television operations centre) for all market open ceremonies. The feed is named TSX Transmit 1 (SD-SDI) and is produced at the TMX Broadcast Centre and sent live to the TOC. To pick up the feed via the Dejero network, please contact firstname.lastname@example.org. The client feature video will begin playing on the TMX media wall at approximately 9:27 a.m. ET and the markets will open with the sound of a siren at 9:30 a.m. ET
Date: Friday, August 7, 2020
Time: 9:00am - 9:30am
Place: Virtually Broadcast
SOURCE TMX Group Limited
Upcoming Life Sciences Events
- September 2020
- Washington: The World Vaccine Congress Washington
- Brussels: The Pharma Business Development Course
- October 2020
- Maryland Life Sciences Bio Innovation Conference